Skip to main content
. 2020 Aug 21;19:58–77. doi: 10.1016/j.omtm.2020.08.014

Figure 1.

Figure 1

Bispecific IgG Formats Reported to Enhance Brain Exposure of Proteins

(A) Tetravalent bispecific format fusing two Aβ ScFvs to the C-terminal heavy chains of a high affinity TfR antibody.12 (B) Bivalent high or medium affinity TfR antibody fusing two payload proteins to the C-terminal heavy chains.13,16, 17, 18 (C) Tetravalent bispecific format fusing two Aβ ScFvs to the C-terminal light chains of a therapeutic antibody.14 (D) Brain shuttle format fusing one TfR scFab to one of the IgG heavy chain.15 (E) Divalent bispecific format.22 (F) Therapeutic antibody with TfR affinity engineered in its Fc domain.20 (G) Tribody format linking two anti-Aβ ScFvs to an anti-TfR Fab.21 (H and I) DVDs23 and TBTIs24. Blue, TfR; green, Aβ; pink, BACE1 recognizing paratopes; yellow, payload proteins such as IL-1 receptor antagonist,17 TNF-alpha decoy receptor protein,13 GDNF,18 or lysosomal enzymes such as iduronate sulfatase.16